At IMMT we are developing solutions to the problem of antibiotic-resistant bacteria, which is causing deaths globally. We are in the process of making new antibiotics from nature by industrializing an original discovery approach. IMMT solutions are based on our group founder Aleš Lapanje, PhD. He has been pursuing his vision for 15 years on over 40 academic and industrial projects, and raised more than €5 million of funding.